Immunitybio Inc
NASDAQ:IBRX

Watchlist Manager
Immunitybio Inc Logo
Immunitybio Inc
NASDAQ:IBRX
Watchlist
Price: 2.53 USD Market Closed
Market Cap: 2.2B USD

Intrinsic Value

The intrinsic value of one IBRX stock under the Base Case scenario is 9.64 USD. Compared to the current market price of 2.53 USD, Immunitybio Inc is Undervalued by 74%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IBRX Intrinsic Value
9.64 USD
Undervaluation 74%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Immunitybio Inc

Valuation History Unavailable

Historical valuation for IBRX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Immunitybio Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Immunitybio Inc

Current Assets 109.2m
Cash & Short-Term Investments 61.6m
Receivables 17.5m
Other Current Assets 30.1m
Non-Current Assets 194.6m
PP&E 167.1m
Intangibles 15.4m
Other Non-Current Assets 12.1m
Efficiency

Free Cash Flow Analysis
Immunitybio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Immunitybio Inc

Revenue
31.2m USD
Cost of Revenue
-7.2m USD
Gross Profit
24m USD
Operating Expenses
-337.4m USD
Operating Income
-313.4m USD
Other Expenses
-95.7m USD
Net Income
-409.1m USD
Fundamental Scores

IBRX Profitability Score
Profitability Due Diligence

Immunitybio Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Exceptional ROE
50/100
Profitability
Score

Immunitybio Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

IBRX Solvency Score
Solvency Due Diligence

Immunitybio Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
27/100
Solvency
Score

Immunitybio Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IBRX Price Targets Summary
Immunitybio Inc

Wall Street analysts forecast IBRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IBRX is 11.48 USD with a low forecast of 4.29 USD and a high forecast of 31.5 USD.

Lowest
Price Target
4.29 USD
70% Upside
Average
Price Target
11.48 USD
354% Upside
Highest
Price Target
31.5 USD
1 145% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Immunitybio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IBRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IBRX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IBRX stock?

The intrinsic value of one IBRX stock under the Base Case scenario is 9.64 USD.

Is IBRX stock undervalued or overvalued?

Compared to the current market price of 2.53 USD, Immunitybio Inc is Undervalued by 74%.

Back to Top